Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-08-09
2010-02-23
Schultz, JD (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
07667028
ABSTRACT:
Short interfering RNA (siRNA) molecules which modulate the expression of an angiogenesis-related gene by RNA interference are described. Short hairpin RNA (shRNA) molecules comprising said siRNA molecules are also described. These molecules can target all, or specific, isoforms of the gene. The use of these molecules and of isoforms of the gene for the treatment and diagnosis of angiogenesis-related disorders is also described.
REFERENCES:
patent: 6943241 (2005-09-01), Isogai et al.
patent: WO 03/027285 (2003-04-01), None
BionomicBIO2004 presentation, presented Jun. 9, 2004.
Katoh et al. (International Journal of Molecular Medicine, 2004 vol. 14:333-338).
Weimann et al.Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Research, vol. 11, (2001), pp. 422-435.
Written Opinion of the International Searching Authority corresponding to the PCT application No. PCT/AU05/01188 dated Oct. 10, 2005.
International Preliminary Report on Patentability corresponding to the PCT application No. PCT/AU05/01188 dated Feb. 13, 2007.
International Search Report corresponding to the PCT application No. PCT/AU05/01188 dated Oct. 10, 2005.
Altschul et al.Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research, vol. 25, No. 17, (1997), pp. 3389-3402.
Augustin, Hellmut G.Antiangiogenic tumour therapy: will it work? TiPS, vol. 19, (1998), pp. 216-222.
Barrett et al.The structure of the GTPase-activating domain from p5OrhoGAP. Nature, vol. 385, (1997), pp. 458-461.
Bayless et al. TheCdc-42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. Journal of Cell Science, vol. 115, (2002), pp. 1123-1136.
Breaker et al.A DNA enzyme with Mg2+-dependent RNA phosphoesterase activity. Chemistry and Biology, vol. 2, (1995), pp. 655-660.
Chrzanowska-Wodnicka et al.Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. The Journal of Cell Biology, vol. 133, No. 6, (1996), pp. 1403-1415.
Cole et al.Human monoclonal antibodies. Molecular and Cellular Biochemistry, vol. 62, (1984), pp. 109-120.
Cote et al.Generation of human monoclonal antibodies reactive with cellular antigens. Proceedings of the National Academy of Sciences of USA, vol. 80, (1983), pp. 2026-2030.
Etlenne-Manneville et al.Rho GRPases in cell biology. Nature, vol. 420, (2002), pp. 629-635.
Gamble et al.Regulation of in vitro capillary tube formation by anti-integrin antibodies. The Journal of Cell Biology, vol. 121, No. 4, (1993), pp. 931-943.
Gamble et al. B1integrin activation inhibits in vitro tube formation: effects on cell migration, vacuole coalescence and lumen formation. Endothelium, vol. 7, No. 1, (1999), pp. 23-34.
Goldman et al.In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nature Biotechnology, vol. 15, (1997), pp. 462-466.
Green et al.Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nature Genetics, vol. 7, (1994), pp. 13-21.
Hanahan, Douglas.Signaling vascular morphogenesis and maintenance. Science, vol. 277, No. 5322, (1997), pp. 48-50.
Maisonpierre et al.Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, vol. 277, (1997), pp. 55-60.
Haseloff et al.Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature, vol. 334, (1988), pp. 585-591.
Heller at al.Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proceedings of the National Academy of Sciences of USA, vol. 94, (1997), pp. 2150-2155.
Hippenstiel et al. Rho protein inactivation induced apoptosis of cultured human endothelial cells. American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 283, (2002), pp. L830-L838.
Huse et al.Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science, vol. 246, (1989), pp. 1275-1281.
Kohler et al.Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, vol. 256, (1975), pp. 495-497.
Kozbor et al.Specific immunoglobulin production and enhanced tumorigenicity following ascites growth of human hybridomas. Journal of Immunological Methods, vol. 81, (1985), pp. 31-42.
Lonberg et al.Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature, vol. 368, (1994), pp. 856-859.
Mackay et al.Rho GRPases. The Journal of Biological Chemistry, vol. 273, No. 33, (1998), pp. 20685-20688.
Meyer et al.Lumen formation during angiogenesis in vitro involves phagocutic activity, formation and secretion of vacuoles, cell death, and capillary tube remodeling by different populations of endothelial cells. The Anatomical Record, vol. 249, (1997), pp. 327-340.
Musacchio et al.Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 α subunit. Proceedings of the National Academy of Sciences of USA, vol. 93, (1996), pp. 14373-14378.
Nobes et al.Rho GRPases control polarity, protrusion, and adhesion during cell movement. The Journal of Cell Biology, vol. 144, No. 6, (1999), pp. 1235-1244.
Orlandi et al.Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proceedings of the National Academy of Sciences of USA, vol. 86, (1989), pp. 3833-3837.
Rickert et al.B lymphocyte-specific, cre-mediated mutagenesis in mice. Nucleic Acids Research, vol. 25, No. 6, (1997), pp. 1317-1318.
Rittinger et al.Structure at 1.65 A of RhoA and its GRPase-activating protein in complex with a transition-state analogue. Nature, vol. 389, (1997), pp. 758-762.
Scharf et al.6 heat stress promoters and transcription factors. Results and Problems in Cell Differentiation, vol. 20, (1994), pp. 125-162.
Schena et al.Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proceedings of the National Academy of Sciences of USA, vol. 93, (1996), pp. 10614-10619.
Schwenk et al.A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Research, vol. 23, No. 24, (1995), pp. 5080-5081.
Van Aelst et al.Rho GRPases and signaling networks. Genes and Development, vol. 11, (1997), pp. 2295-2322.
Winter et al.Man-made antibodies. Nature, vol. 349, (1991), pp. 293-299.
Wojciak-Stothard et al.Rho and Rac but not Cdc42 regulate endothelial cell permeability. Journal of Cell Science, vol. 114, (2001), pp. 1343-1355.
Kremmidiotis Gabriel
Lavranos Tina Christine
Leske Annabell Frances
Bionomics Limited
Gibbs Terra Cotta
Jenkins Wilson Taylor & Hunt, P.A.
Schultz JD
LandOfFree
Compositions and methods for angiogenesis-related molecules... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for angiogenesis-related molecules..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for angiogenesis-related molecules... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4205144